Regeneron Pharmaceuticals Inc.
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase[...]
Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)
04/25/2024 | Press release | Distributed by Public on 04/25/2024 07:07
Please select the service you want to use:
Smartlinks | Encavis AG | Company News | Shareholders | Shareholder Meeting | Energy | Renewable Energy Industry | Securities Issuers | Wind Systems and Equipment Manufacturers | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Six Swiss Exchange | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | OTC Markets | BX Swiss | Tradegate Exchange | XETRA | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | SIGMA X MTF | Equiduct | Euronext Block MTF | Hannover Stock Exchange | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact